Global Biomarker Technologies Market Segmentation, By Product (Consumables, Instruments, Services, Software/Informatics), Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay), Test Type (Liquid Biopsy, Solid Biopsy), Research Area (Genomics, Proteomics, Metabolomics, Other Research Areas), Application (Biomarker Identification, Validation and Development Research, Routine Biomarker-based Tests) – Industry Trends and Forecast to 2031.
Biomarker Technologies Market Analysis
Patterns of gene expression are widely utilized to identify various diseases. Biomarkers are used in diagnosis of various diseases such as infectious diseases, cancer, autoimmune diseases, and others. The increase in prevalence of various diseases is rising the demand for biomarker technologies.
Biomarker Technologies Market Size
Global biomarker technologies market size was valued at USD 42.03 billion in 2023 and is projected to reach USD 122.02 billion by 2031, with a CAGR of 14.25% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Biomarker Technologies Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others
|
Biomarker Technologies Market Definition
Biomarker refers to a biological characteristic that is measured and evaluated as a maker of pathological processes or normal biological or a response to a therapeutic intervention. Biomarkers are widely utilized in diagnosis of various diseases, such as infectious diseases, cancer, and autoimmune diseases, among others.
Biomarker Technologies Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Funds and Grants
The surge in investments in the form of funds and grants for biomarker research accelerate the market growth.
- Diagnostic Biomarker Technology
The inclination from conventional approach of pathophysiology/epidemiology to biomarker studies due to the technological advances further influence the market.
- Prevalence of Cancer
The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarker technologies market.
Opportunities
Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, continuous product innovation will further expand the market.
Restraints/Challenges
On the other hand, the high capital investments and lengthy timelines for biomarker development are expected to obstruct market growth. Also, technical issues related to sample collection and storage are projected to challenge the biomarker technologies market in the forecast period of 2024-2031.
This biomarker technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biomarker technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Biomarker Technologies Market
Covid-19 had a positive impact on the biomarker technologies market. The increase in the number of COVID-19 accelerated the development of the biomarker technologies. Chinese research team pinpointed SARS-CoV-2 coronavirus infection from the molecular markers in the blood that are predictive of acute COVID-19. The biomarkers have become essential in clinical decision making for numerous infectious diseases treatment procedures.
Biomarker Technologies Market Scope
The biomarker technologies market is segmented on the basis of product, profiling technology, test type, research area and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
- Services
- Software/Informatics
Profiling Technology
- Chromatography
- NGS
- PCR
- Mass Spectrometry
- Immunoassay
Test Type
- Liquid Biopsy
- Solid Biopsy
Research Area
- Genomics
- Proteomics
- Metabolomics
- Other Research Areas
Application
- Biomarker Identification
- Validation and Development Research
- Routine Biomarker-Based Tests
Biomarker Technologies Market Regional Analysis
The biomarker technologies market is analyzed and market size insights and trends are provided by country, product, profiling technology, test type, research area and application as referenced above.
The countries covered in the biomarker technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biomarker technologies market because of the rise in geriatric population, and support from private and public organizations within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the rise in awareness related to early screening of cancer for better treatment in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Biomarker Technologies Market Share
The biomarker technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biomarker technologies market.
Biomarker Technologies Market Leaders Operating in the Market Are:
- Enzo Biochem Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Merck KGaA (Germany)
- PerkinElmer Inc. (US)
- QIAGEN (Germany)
- Agilent Technologies, Inc. (US)
- Bruker (US)
- Epigenomics AG (Germany)
- MESO SCALE DIAGNOSTICS, LLC (US)
- EKF Diagnostics Holdings plc (UK)
- General Electric Company (US)
- Nexus-Dx (US)
- LifeSign LLC (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
Latest Developments in Biomarker Technologies Market
- F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high sensitive cardiac troponin T (cTnT-hs) in April’2021. The cardiac biomarkers assist clinicians in diagnosing heart attacks and manage heart failure better
- QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May’2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options
SKU-